GuidanceMedical PhysicistMammography FacilityLead Interpreting PhysicianRadiologic TechnologistMQSA InspectorCompliance Officer

Quality Mammography Standards: Correcting Amendment to 21 CFR Part 900 (FR Doc. 98-28148)

63 FR 56555 · Docket No. 95N-0192 · Effective April 28, 1999

Last Reviewed: August 21, 2026

Publisher
U.S. Food and Drug Administration / Federal Register
Author
William K. Hubbard, Associate Commissioner for Policy Coordination, FDA
Edition
Final Rule — 63 FR 56555, 1998
Pages
5 pages
Added to library
Added August 21, 2026
Loading document…

Overview

This five-page Federal Register final rule (Vol. 63, No. 204, October 22, 1998) is the definitive correcting amendment to the comprehensive MQSA quality standards rule published October 28, 1997 (62 FR 55852), itself partly corrected in a republication of November 10, 1997 (62 FR 60614) that introduced additional errors. The 1998 correcting amendment addresses 12 distinct problems across eight sections of 21 CFR Part 900: definitions (§900.2(d)), personnel qualifications (§900.12(a)(2)(ii), (a)(2)(iv)(A), (a)(3)(iii)(B)), records (§900.12(c)(4)(i), (c)(4)(ii), (d)(2)), equipment QC (§900.12(e)(1), (e)(4)(iii)(B), (e)(8)(ii)(A), (e)(10)), and the medical outcome audit (§900.12(f)(3)). Effective April 28, 1999 for most provisions, with §900.12(e)(4)(iii)(B) (compression force limit) effective October 28, 2002. Signed by William K. Hubbard, Associate Commissioner for Policy Coordination, October 6, 1998.

Key Contents

-Regulatory action: Final rule; correcting amendment | Docket No. 95N-0192 | FR Doc. 98-28148 | RIN 0910-AA24

-Published: Federal Register Vol. 63, No. 204 (October 22, 1998), pages 56555–56559

-Effective date: April 28, 1999 (except §900.12(e)(4)(iii)(B): October 28, 2002)

-Signed: William K. Hubbard, Associate Commissioner for Policy Coordination, October 6, 1998

-Contact: Roger L. Burkhart, CDRH (HFZ-240), FDA, 1350 Piccard Dr., Rockville, MD 20850 | 301-594-3332

-12 corrections across 8 sections:

A. §900.2(d): Air kerma definition

Fixed editorial error conflating 'rad' with 'radian'; clarified that in air, 1 Gy of absorbed dose is delivered by 114 roentgens (R) of exposure.

B. §900.12(a)(2)(ii): Technologist mammography requirements (grandparenting provision)

Added 'of FDA's interim regulations' to eliminate ambiguous cross-reference to paragraph (a)(2), clarifying that grandparenting applies to interim (not final) regulations.

C. §900.12(a)(2)(iv)(A): Technologist continuing experience

Date changed from October 28, 1997 (publication date) to April 28, 1999 (effective date) to prevent retroactive application; 'preceding the inspection' added to the calendar quarter reference. Compliance checking begins after June 30, 2001.

D. §900.12(a)(3)(iii)(B): Medical physicist continuing experience

'on' corrected to 'or' in the survey requirement; 'the total mammography units survey' replaced with 'this'; date corrected from October 28, 1997 to April 28, 1999; 'preceding the inspection' added.

OPERATIVE TEXT: Physicist must survey ≥2 facilities and ≥6 total units in the 24 months preceding annual MQSA inspection. No more than one survey of a specific facility within 10 months, or a specific unit within 60 days, may count.

E. §900.12(c)(4)(i): Maintenance of records

Cross-reference corrected from '(c)(3)(ii)' to '(c)(4)(ii)': a citation error with significant compliance consequences.

F. §900.12(c)(4)(ii): Transfer of records

'by' moved to correct position; facility must transfer mammograms 'on behalf of' the patient, not the previous garbled phrasing.

G. §900.12(d)(2): Quality assurance records

'Employee qualifications to meet assigned quality assurance tasks' moved to last position in the records list (was first, creating two possible interpretations). 'These' changed to 'the' in the second sentence.

H. §900.12(e)(1): Daily quality control tests

'Examinations' → 'films' and 'performed' → 'processed' completed for second occurrence in paragraph (first set had been corrected in November 1997 republication).

I. §900.12(e)(4)(iii)(B): Compression force (effective October 28, 2002)

CRITICAL: Upper limit corrected from 209 newtons (47 lbs) to 200 newtons (45 lbs). The maximum compression force from the initial power drive must be between 111 newtons (25 lbs) and 200 newtons (45 lbs).

J. §900.12(e)(8)(ii)(A): Tests requiring corrective action before further clinical use

Section citations corrected. Tests triggering mandatory pre-use corrective action: §900.12(e)(1), (e)(2), (e)(4)(i), (e)(4)(ii), (e)(4)(iii), (e)(5)(vi), (e)(6), or (e)(7).

K. §900.12(e)(10): Mammography equipment evaluations

'Dissembled' corrected to 'disassembled.'

L. §900.12(f)(3): Reviewing interpreting physician (medical outcome audit)

Comma replaced with 'and for': corrects incomplete sentence. Reviewing physician is responsible for: (1) documenting the results AND (2) notifying other interpreting physicians of their results and facility aggregate results.

How This Applies to Your Practice

This correcting amendment contains several provisions with direct, ongoing compliance implications that MQSA inspectors still evaluate. The compression force correction (correction I), 200 newtons / 45 lbs maximum from the power drive, remains the active regulatory standard and is a routine QC test item. The medical physicist continuing experience correction (correction D) defines the operative language governing physicist qualification: ≥2 facilities, ≥6 units, 24 months preceding the annual MQSA inspection. The records transfer correction (correction F) governs how facilities must respond to patient mammogram requests. The medical outcome audit correction (correction L) established the reviewing interpreting physician's obligation to notify other physicians of their individual results: an inspection-verified requirement. Facilities and MammoComply users should note that the version of 21 CFR Part 900 they reference must incorporate these 1998 corrections, as errors in the 1997 original text created compliance traps.

Practitioner Implications

Key active compliance items corrected by this document: (1) Maximum compression force from power drive is 200 newtons (45 lbs), not 209 newtons; (2) Medical physicist must survey ≥2 facilities and ≥6 units in 24 months preceding the annual MQSA inspection, no more than one survey of a specific facility in 10 months or a specific unit in 60 days; (3) Reviewing interpreting physician must both document medical outcome audit results AND notify other interpreting physicians of their individual and aggregate results; (4) Records transfer citation in §900.12(c)(4)(i) correctly references §900.12(c)(4)(ii). Facilities and physicists using the original October 28, 1997 final rule text without these corrections are working from an erroneous regulatory source.

Disclaimer

The content, articles, calculators, tools, estimates, projections, derived data, reports, and other materials provided by Mammologix, LLC, powered by I/O Trak, Inc. (“Mammologix”) are provided for informational and educational purposes only.

The information and outputs provided by Mammologix are not intended to serve as, and should not be relied upon as, medical advice, diagnosis, treatment, clinical guidance, financial advice, investment advice, tax advice, legal advice, accounting advice, or any other professional advice.

Information provided by Mammologix may relate to breast health, mammography, imaging, screening, diagnostics, clinical outcomes, healthcare topics, financial calculations, estimates, projections, or other decision-support information. However, such information should not be used to make personal medical, clinical, financial, investment, business, insurance, legal, or other important decisions without consulting an appropriate qualified professional.

Always seek the advice of a licensed physician, radiologist, healthcare provider, financial advisor, accountant, attorney, or other qualified professional with any questions you may have about a medical condition, screening recommendation, imaging result, treatment option, financial matter, or other professional decision. Never disregard professional medical, financial, legal, or other advice, or delay seeking such advice, because of something you have read, calculated, or received through Mammologix.

Any calculators, formulas, estimates, projections, derived medical outcome data, financial calculations, or other tool-generated outputs are provided as estimates only. Results may be affected by user-entered information, assumptions, formula limitations, incomplete or inaccurate data, rounding, software errors, third-party data, changing medical guidelines, changing financial conditions, changes in law or regulation, or other factors. Mammologix does not represent, warrant, or guarantee that any calculation, output, article, estimate, projection, or derived data is accurate, complete, current, reliable, suitable, or appropriate for any particular purpose.

For medical or health-related content and calculators, Mammologix does not provide medical advice, diagnosis, treatment recommendations, diagnostic interpretation, or patient-specific clinical decision-making. Mammologix content and tools are not a substitute for an in-person evaluation, professional medical consultation, diagnostic interpretation, or individualized care from a licensed healthcare provider. In the event of a medical emergency, contact emergency services or a qualified healthcare provider immediately.

For financial, business, tax, investment, or accounting-related calculators or content, Mammologix does not provide financial, investment, tax, legal, accounting, or business advice. Any outputs are estimates only, and actual results may vary materially based on personal circumstances, market conditions, taxes, fees, interest rates, inflation, risk tolerance, regulatory changes, and other factors.

Use of Mammologix content, articles, calculators, tools, and outputs is at your own risk. You are solely responsible for reviewing, verifying, and interpreting any information or results provided and for obtaining appropriate professional advice before relying on or acting upon such information.

Mammologix assumes no liability for any injury, loss, claim, damage, or expense arising from or related to the use of, reliance on, or inability to use any Mammologix content, article, calculator, tool, estimate, projection, derived data, report, or website material. To the fullest extent permitted by law, Mammologix, its owners, officers, employees, contractors, affiliates, licensors, service providers, and agents disclaim all liability for any direct, indirect, incidental, consequential, special, exemplary, punitive, financial, medical, clinical, business, or other damages arising out of or relating to the use of Mammologix materials or outputs.

The information provided by Mammologix does not establish a doctor-patient, provider-patient, radiologist-patient, financial advisor-client, attorney-client, accountant-client, fiduciary, or other professional relationship.

AI Content Disclosure

Some Mammologix content, calculations, summaries, tools, or outputs may be created, edited, generated, or assisted by artificial intelligence tools or automated systems. While Mammologix may review content for accuracy and relevance, AI-assisted or automated materials may contain errors, omissions, inaccuracies, outdated information, or outputs that are incomplete or inappropriate for a particular user, patient, circumstance, or purpose.

Users should independently verify all AI-assisted content, calculator outputs, and automated results with appropriate qualified professionals before relying on them.

Didn't find what you were looking for?

Our team has supported breast imaging centers since 1995. If it's not here, we probably know the answer.

Ask a Question →